Filing Details
- Accession Number:
- 0001628280-24-045329
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-05 16:39:01
- Reporting Period:
- 2024-10-01
- Accepted Time:
- 2024-11-05 16:39:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 1600 West End Ave. Suite 1300 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-01 | 62 | $1.27 | 5,698,657 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-02 | 62 | $1.29 | 5,698,719 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-03 | 62 | $1.28 | 5,698,781 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-04 | 62 | $1.28 | 5,698,843 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-07 | 62 | $1.29 | 5,698,905 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-08 | 62 | $1.30 | 5,698,967 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-09 | 62 | $1.31 | 5,699,029 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-10 | 62 | $1.32 | 5,699,091 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-11 | 62 | $1.39 | 5,699,153 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-14 | 62 | $1.37 | 5,699,215 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-15 | 62 | $1.30 | 5,699,277 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-16 | 62 | $1.25 | 5,699,339 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-17 | 62 | $1.30 | 5,699,401 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-18 | 62 | $1.28 | 5,699,463 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-21 | 62 | $1.25 | 5,699,525 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-22 | 62 | $1.25 | 5,699,587 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-23 | 62 | $1.26 | 5,699,649 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-24 | 62 | $1.24 | 5,699,711 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-25 | 62 | $1.23 | 5,699,773 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-28 | 62 | $1.25 | 5,699,835 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-29 | 62 | $1.24 | 5,699,897 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-30 | 62 | $1.32 | 5,699,959 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-31 | 62 | $1.20 | 5,700,021 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Billionaire Hedge Funds
